Pharmaceuticals · PSX stock comparison
AGP vs GlaxoSmithKline (GLAXO)
AGP Limited and GlaxoSmithKline Pakistan Limited: compare valuation, dividends and financial performance side by side.
AGP Limited
Rs 153.52
PSX snapshot · 18/11/2026, 17:13:00 PKT
GlaxoSmithKline Pakistan Limited
Rs 333.13
PSX snapshot · 18/11/2026, 17:13:00 PKT
| Metric | AGP | GLAXO |
|---|---|---|
| Market & valuationPSX quotes; issuer filings and dated SCSTrade fundamentals | ||
| Share price | Rs 153.52 | Rs 333.13 |
| P/E (TTM) | 24.03× | 9.66× |
| Annual dividend yield | 5.21%FY 2025 | 5.10%FY 2025 |
| Annual dividend per share | Rs 8.00FY 2025 | Rs 17.00FY 2025 |
| Price / book (calculated) | 3.62×2026 Q2 | 3.08×2026 Q2 |
| Market cap | Rs 42.99B | Rs 106.09B |
| 1-year price change · excluding payouts | -16.46% | -14.20% |
| Profitability & financial healthIssuer filings / SCSTrade · period and source shown per figure | ||
| Book value per share | Rs 42.392026 Q2 | Rs 108.122026 Q2 |
| Return on equity (ROE) | 18.27%2025 Q4 | 29.77%2025 Q4 |
| Return on assets (ROA) | 11.55%2025 Q4 | 19.78%2025 Q4 |
| Gross profit margin | 48.62%2025 Q4 | 37.00%2025 Q4 |
| Net profit margin | 11.49%2025 Q4 | 15.21%2025 Q4 |
| Inventory turnover | 4.71×2025 Q4 | 5.16×2025 Q4 |
| Current ratio | 0.92×2026 Q2 | 2.28×2026 Q2 |
| Quick ratio | 0.41×2025 Q4 | 1.48×2025 Q4 |
Sources & reporting periods
Prices and trailing P/E: PSX DPS. Annual yield = full-year cash dividend divided by displayed PSX price. Annual dividends and financial ratios: reviewed issuer filings and SCSTrade. Financial year and dividend/share are shown for both stocks; unclear feed yields are excluded. Price/book uses reported book value. PSX 1-year price changes exclude payouts; they are not total returns. Reviewed issuer ratios use unconsolidated statements and labelled year-end denominators. Unverified borrowing ratios are omitted.
More pharmaceuticals comparisons
Pharmaceuticals
Pharmaceutical companies: compare profitability, returns and working capital.
